The links between obstructive sleep apnoea and hypertension are well established; obstructive sleep apnoea is reported in up to 30% of patients with hypertension, although it is frequently underdiagnosed. Physicians can assess the degree of sleepiness by administering the Epworth Sleepiness Scale, but the large number of patients with hypertension makes this strategy difficult for busy physicians to implement. Obese patients form a subgroup at higher risk for obstructive sleep apnoea, which can be targeted for screening.
INTRODUCTION
Obstructive sleep apnoea affects 5% of the adult population, 1 and is characterised by collapse of the upper airway resulting from the loss of waking neuromuscular drive as the brain changes from wakefulness to sleep. The links between obstructive sleep apnoea and high blood pressure are well established, particularly among patients with resistant hypertension; 2 and obstructive sleep apnoea is reported in up to 30% of patients with hypertension, although it is frequently underdiagnosed. [3] [4] [5] [6] [7] Long-term treatment of obstructive sleep apnoea by continuous positive airway pressure (CPAP) has been shown to improve blood pressure control, even in patients with refractory hypertension. 7 The role of obstructive sleep apnoea in hypertension has been recognised by the European 2007 Guidelines for the Management of Arterial Hypertension, 8 which state that '... this syndrome may contribute to the elevated pressure in a large proportion of hypertensive patients' and that 'untreated obstructive sleep apnoea may have direct and deleterious effects on cardiovascular function and structure'. Identification of obstructive sleep apnoea in patients with hypertension is therefore an important target in clinical practice. Unfortunately, neither the European guidelines 8 suggests any strategy to detect obstructive sleep apnoea in clinical practice, while the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (also referred to as the 'JNC 7') implicates obstructive sleep apnoea as a secondary cause of hypertension.
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A simple strategy to identify obstructive sleep apnoea in patients with hypertension could be extremely useful in general practice, allowing blood pressure to be reduced in many patients with 'hard-to-control' hypertension. Physicians can effectively and easily assess the degree of sleepiness by administering the Epworth Sleepiness Scale, 11 a simple, self-administered questionnaire, which provides a measurement of the patient's general level of daytime sleepiness (a moderate/severe score indicates the need of a diagnostic polysomnography). Clinical suspicions of obstructive sleep apnoea must always be confirmed by polysomnography.
Obesity is associated with a fourfold higher prevalence of obstructive sleep apnoea. 12 Patients with obesity and hypertension can be easily identified, frequently visit their GPs, and their combination of conditions may represent the first target to detect and treat obstructive sleep apnoea in primary care.
The aim of the present study was to detect obstructive sleep apnoea among patients with obesity and hypertension and to treat hypertension accordingly. The participating GPs agreed on the need to evaluate the feasibility of this strategy and to verify the effect of treatment of obstructive sleep apnoea on blood pressure control.
METHOD
Three GPs, caring for a total of 4514 people (aged ≥18 years) decided to improve blood pressure control in obese hypertensive individuals. They identified obstructive sleep apnoea as an important problem in this group of patients, and the Epworth Sleepiness Scale (Box 1) 11 as a simple tool for initial screening of obstructive sleep apnoea. First they identified all their patients with hypertension on stable pharmacological treatment. To simplify the screening, the GPs decided to exclude patients with relevant pulmonary or neurological diseases, or those affected by insomnia. All the remaining obese patients (body mass index [BMI] >30 kg/m
2 ) with hypertension were tested with the Epworth Sleepiness Scale.
All the patients with an Epworth Sleepiness Scale score greater than 11 points 11 underwent an overnight polysomnography and 24-hour ambulatory blood pressure monitoring. Overnight polysomnography ('SOMNOcheck effort' polysomnograph, Weinmann, Germany) was performed between 22.00 and 06.00 at the local sleep-disorder medicine department at Garibaldi Hospital, Catania, Italy. A diagnosis of obstructive sleep apnoea was established following the guidelines of the Institute for Clinical Systems Improvement. 13 Blood pressure recordings were performed by GPs using a non-invasive device (Takeda TM-2430, A&D Medical, Tokyo, Japan) validated by the British Hypertension Society (grade AA for approved hospital grade accuracy), 14 according to the standards of the British Hypertension Society, 14 before treatment of the obstructive sleep apnoea. Blood pressure was evaluated according to the European Society of Hypertension recommendations. 8 All patients with a diagnosis of obstructive sleep apnoea were offered appropriate lifestyle counselling and auto-adjusting
How this fits in
Obstructive sleep apnoea may contribute to elevated blood pressure in a large proportion of patients with hypertension. Although continuous positive airway pressure has been shown to improve blood pressure control in patients with obstructive sleep apnoea, this problem remains under-diagnosed. The Epworth Sleepiness Scale is a simple tool that may help to identify obstructive sleep apnoea in general practice. Screening obese patients with hypertension with this tool is feasible and permits diagnosis and treatment of obstructive sleep apnoea in about 10% of these patients. (SD 6.27 ). These patients represent 10% (95% confidence interval [CI] = 7.03% to 13.63%) of the observed obese hypertensive population and 3.9% (95% CI = 2.74% to 5.51%) of the whole stable hypertensive population. All these 30 patients accepted the use of CPAP, and no-one discontinued the treatment.
After 12 weeks of CPAP, all patients were reevaluated; in the intervening period, no significant weight loss was observed and there were no changes in drug therapy. The results of 24-hour blood pressure monitoring at baseline and after CPAP are summarised in Table 1 
DISCUSSION

Summary of main findings
Use of the Epworth Sleepiness Scale in obese patients with hypertension identified obstructive sleep apnoea in about 10% of patients and the diagnosis was confirmed by polysomnography in all but one patient. All patients with obstructive sleep apnoea were considered suitable for CPAP. The use of nasal CPAP in these patients greatly improved blood pressure control in all cases.
Strengths and the limitations of this study
The most important limitation of the study is the small number of participating GPs and, therefore, examined patients. It is probable that the detection strategy missed some obstructive sleep apnoea among patients with hypertension. On the other hand, the aim of the audit was not identification of the patients with hypertension and obstructive sleep apnoea, but to implement and test a simple strategy to identify some of them. In the authors' opinion, this approach is feasible in everyday practice and permits a useful improvement when compared with the actual practice of episodic or occasional diagnosis of obstructive sleep apnoea. A possible strength of the study is the completeness of the data: all the patients with hypertension on stable pharmacological therapy were considered, and all the patients with suspected obstructive sleep apnoea underwent further treatment. suggests a strategy to detect obstructive sleep apnoea in clinical practice. By being aware of the symptoms, predisposing factors, and comorbidities associated with obstructive sleep apnoea, primary care providers can play a vital role in screening their patients.
Comparison with existing literature
Medical providers can assess the degree of sleepiness very effectively and easily by administering the Epworth Sleepiness Scale, 11 but polysomnography is always required to confirm the diagnosis of obstructive sleep apnoea. The Epworth Sleepiness Scale is also the preferred method to assess degree of residual sleepiness after treatment initiation. 11 In the authors' opinion, testing all patients with hypertension using the Epworth Sleepiness Scale is neither adequately supported by scientific evidence, nor feasible in usual care, at least in Italy. Only simple diagnostic strategies, focused on a limited number of individuals, can be implemented by busy physicians caring for hundreds of patients with hypertension.
Obesity is associated with a fourfold higher obstructive sleep apnoea prevalence, 12 affects only a minority of patients with high blood pressure, and can be immediately suspected and assessed. Obese patients with hypertension can therefore be suitably targeted for obstructive sleep apnoea screening. As far as the authors know, such a strategy has not yet been tested in clinical practice.
Implications for clinical practice and future research
The Epworth Sleepiness Scale can be easily used to identify obstructive sleep apnoea among patients with obesity and hypertension in primary care. About 10% of these patients are consequently diagnosed with this disorder. CPAP may reduce high blood pressure in this subgroup of patients, possibly avoiding the use of additional antihypertensive drugs. This simple screening strategy may be easily adopted by GPs in everyday practice, thus benefiting thousands of patients nationwide. Such a generalised effort would be recommended if other larger studies confirm the current results.
